ChemoCentryx Inc. (NASDAQ:CCXI)’s share price traded down 2.2% during trading on Monday . The company traded as low as $4.74 and last traded at $4.89, with a volume of 74,188 shares. The stock had previously closed at $5.00.

A number of equities analysts have commented on the stock. JPMorgan Chase & Co. reissued a “buy” rating and issued a $11.00 price target on shares of ChemoCentryx in a research note on Tuesday, August 9th. Cowen and Company reissued a “hold” rating on shares of ChemoCentryx in a research note on Thursday, May 19th. Finally, Zacks Investment Research cut shares of ChemoCentryx from a “buy” rating to a “hold” rating in a research note on Monday, May 16th.

The firm has a 50 day moving average price of $4.58 and a 200 day moving average price of $3.84. The firm’s market capitalization is $234.99 million.

ChemoCentryx, Inc (ChemoCentryx) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing orally-administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders and cancer. It targets the chemoattractant system, which is a network of molecules, including chemokine ligands and their associated receptors, as well as related chemoattractant receptors.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.